临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2014年
9期
1646-1648
,共3页
杜凤华%陶满意%张雷%李玉勤
杜鳳華%陶滿意%張雷%李玉勤
두봉화%도만의%장뢰%리옥근
结核分枝杆菌%肺结核%耐多药%耐二线药
結覈分枝桿菌%肺結覈%耐多藥%耐二線藥
결핵분지간균%폐결핵%내다약%내이선약
mycobacterium tuberculosis%pulmonary tuberculosis%MDR%resistance to second-line drug
目的:了解耐多药肺结核患者对二线抗结核药物的耐药情况。方法对我院住院的341例耐多药肺结核患者二线抗结核药物的耐药情况进行分析。结果341例MDR-TB对左氧氟沙星、丙硫异烟胺、力克肺疾、对氨基水杨酸、丁胺卡那霉素、卷曲霉素的总耐药率依次为49.9%、26.4%、24.9%、23.4%、18.5%、15.8%。复治组对二线抗结核药物的耐多药率明显高于初治组,不合理治疗是形成MDR-TB或XDR-TB的主要原因。结论耐多药肺结核患者对二线抗结核药物耐药情况严重,要引起重视。
目的:瞭解耐多藥肺結覈患者對二線抗結覈藥物的耐藥情況。方法對我院住院的341例耐多藥肺結覈患者二線抗結覈藥物的耐藥情況進行分析。結果341例MDR-TB對左氧氟沙星、丙硫異煙胺、力剋肺疾、對氨基水楊痠、丁胺卡那黴素、捲麯黴素的總耐藥率依次為49.9%、26.4%、24.9%、23.4%、18.5%、15.8%。複治組對二線抗結覈藥物的耐多藥率明顯高于初治組,不閤理治療是形成MDR-TB或XDR-TB的主要原因。結論耐多藥肺結覈患者對二線抗結覈藥物耐藥情況嚴重,要引起重視。
목적:료해내다약폐결핵환자대이선항결핵약물적내약정황。방법대아원주원적341례내다약폐결핵환자이선항결핵약물적내약정황진행분석。결과341례MDR-TB대좌양불사성、병류이연알、력극폐질、대안기수양산、정알잡나매소、권곡매소적총내약솔의차위49.9%、26.4%、24.9%、23.4%、18.5%、15.8%。복치조대이선항결핵약물적내다약솔명현고우초치조,불합리치료시형성MDR-TB혹XDR-TB적주요원인。결론내다약폐결핵환자대이선항결핵약물내약정황엄중,요인기중시。
Objective To study the drug resistance of MDR-TB patients to second-line drug. Methods The drug resistance of 341 MDR-TB patients to second-line drug was analyzed in our hospital. Results The drug re-sistance rate of 341 MDR-TB patients to levofloxacin, prothionamide, isoniazid aminosalicylate, P-aminosalicylic acid, amikacin and capreomycin were 49. 9%, 26. 4%, 24. 9%, 3. 4%, 18. 5% and 15. 8% respectively. The multi-drug resistant rate of second-line anti-TB drugs in the retreatment group was higher than that in the initial treat-ment group. Unreasonable treatment was the main reason for the formation of MDR-TB or XDR-TB. Conclusion The drug resistance of MDR-TB patients to second-line drug is in serious condition, which must be paid more atten-tion.